Beauty Health Co(SKIN)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$10.52
10/26/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for SKIN

10/26/2026: SKIN (1-star) is currently NOT-A-BUY. Pass it for now.

The Beauty Health Company is a growth-oriented firm in the aesthetic industry, known primarily for its HydraFacial device and related high-margin consumables. The company benefits from a recurring revenue model and a strong brand presence within the professional skin health space. However, it faces risks, including intense competition from alternative aesthetic technologies, operational challenges, and sensitivity to discretionary spending. Investors should consider that while the company has potential for international expansion, its financial performance has been inconsistent. It is best suited for growth-oriented investors who can tolerate volatility and are monitoring the impact of recent sales restructuring and leadership stability.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitThe company offers exposure to high-growth aesthetics but faces significant execution and profitability hurdles.
Momentum investorWeak fitThe stock has experienced high volatility and is currently sensitive to a lack of clear, consistent upward price trends.
Value investorMixed fitWhile valuations may appear lower than past peaks, the uncertainty regarding future earnings makes it a complex value proposition.
Dividend investorWeak fitThe company does not pay dividends and focuses entirely on capital reinvestment.
Low-risk investorWeak fitHigh price volatility and operational challenges make this an unsuitable choice for risk-averse investors.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighThe stock exhibits wide price swings common in emerging aesthetic companies.
Valuation riskMediumValuation remains contingent on achieving forecasted growth and margin targets.
Competition risk (Aesthetic Technology)HighRapid innovation from competitors like InMode can erode market share.
Business qualityMediumWhile the brand is strong, operational consistency has been a recent challenge.
Dividend incomeLow / noneThere is no income component for shareholders.
Execution riskHighThe company must successfully navigate organizational and sales restructuring.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type Stock
Historic Profit -64.92%
Avg. Invested days 22
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 10/26/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
SKIN receives a 3-star rating, supported by solid company fundamentals. The rating is constrained by soft unit economics, soft quantitative characteristics, and weak price momentum.

Company Fundamentals

★★★★★
SKIN has solid overall fundamentals (4 stars), with moderate financial health, solid growth momentum, and solid ownership. In FY2025 versus FY2024, strong earnings growth (+67.3%) and solid cash generation (FCF margin 10.7%) are partially offset by negative revenue growth (-10.0%), weak profitability (net margin -3.2%).

Financial Health Rating

★★★★★
SKIN's financial health is supported by solid liquidity, including working-capital and asset support (WC/assets 24.7%). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is SKIN's strongest growth driver at +246.1% FY2025 versus FY2024 (strong, 5 stars). By comparison, earnings growth (+67.3%, strong) is also strong, while revenue growth (-10.0%, negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 77.1% and approximately 39.2% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 12.88% supports management-shareholder alignment.

Top 5 Institutional Investors

Capricorn Fund Managers Ltd 17.12%
FMR Inc 7.84%
BlackRock Inc 6.54%
Millennium Management LLC 5.79%
Vanguard Capital Management, LLC 2.69%

Unit Economics (Per $1K Revenue)

★★★★★
SKIN generates approximately $653 of gross profit, $-69 of operating income, and $107 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Operating losses explain the 2-star rating, with weak cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: -60.31% (Tax Credit)

Quantitative Style Profile

★★★★★
SKIN has a Short Squeeze Candidate profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedSmall / Mid Cap RiskShort Squeeze Risk

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 70.88M USD
Price to earnings Ratio -
1Y Target Price 15.67
Price to earnings Ratio -
1Y Target Price 15.67
Volume (30-day avg) 28.8K shares
Beta 1.05
52 Weeks Range 9.89 - 34.80
Updated Date 10/25/2026
52 Weeks Range 9.89 - 34.80
Updated Date 10/25/2026
Dividends yield (FY) -
Basic EPS (TTM) -4.6

How Company Makes Money

Business areaWhat it includesRetail investor read
HydraFacial SystemsSale of proprietary aesthetic devices to medspas and dermatologists.The upfront revenue from machine sales.
ConsumablesSale of proprietary tips and serums required for every treatment.The recurring high-margin revenue stream.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Advertisement

Valuation

Trailing PE -
Forward PE 106.38
Enterprise Value 380.33M
Price to Sales(TTM) 0.24
Enterprise Value 380.33M
Price to Sales(TTM) 0.24
Enterprise Value to Revenue 1.23
Enterprise Value to EBITDA 18.37
Shares Outstanding 6.51M
Shares Floating 2.55M
Shares Outstanding 6.51M
Shares Floating 2.55M
Percent Insiders 12.88
Percent Institutions 77.06

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.